Why Zepbound Users Lose More Weight Than Wegovy Users

New clinical trial data show that Zepbound users lost significantly more weight than Wegovy users over 72 weeks. Here’s how tirzepatide and semaglutide compare in effectiveness, side effects, cardiovascular benefits, and obesity treatment outcomes.

Micro-dosing GLP-1s: Why NYC Elites Are Taking “Tiny Shots” to Avoid Side Effects

Medical infographic showing how Semaglutide, a GLP-1 peptide hormone, acts on the pancreas, cardiovascular system, liver, and stomach to regulate blood sugar and support weight management.

GLP-1 microdosing offers a gradual, sustainable approach to weight loss and metabolic health. By using lower doses of medications like semaglutide, patients can manage appetite and insulin resistance while minimizing common side effects.